Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.

Al-Nakhle H, Smith L, Bell SM, Burns PA, Cummings M, Hanby AM, Lane S, Parker MD, Hughes TA, Speirs V.

Int J Oncol. 2013 Dec;43(6):2039-45. doi: 10.3892/ijo.2013.2112. Epub 2013 Sep 25.

PMID:
24068253
2.

Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.

Suzuki F, Akahira J, Miura I, Suzuki T, Ito K, Hayashi S, Sasano H, Yaegashi N.

Cancer Sci. 2008 Dec;99(12):2365-72. doi: 10.1111/j.1349-7006.2008.00988.x. Epub 2008 Nov 17.

3.
4.

Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K.

Oncogene. 2003 Oct 23;22(48):7600-6.

PMID:
14576822
5.

Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.

To SQ, Takagi K, Miki Y, Suzuki K, Abe E, Yang Y, Sasano H, Simpson ER, Knower KC, Clyne CD.

J Steroid Biochem Mol Biol. 2012 Nov;132(3-5):331-8. doi: 10.1016/j.jsbmb.2012.07.007. Epub 2012 Aug 19.

PMID:
22929011
6.
7.

Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.

Zhang C, Li H, Zhou G, Zhang Q, Zhang T, Li J, Zhang J, Hou J, Liew CT, Yin D.

J Pathol. 2007 Jun;212(2):134-42.

PMID:
17471463
8.

Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

Zhang YW, Staal B, Dykema KJ, Furge KA, Vande Woude GF.

PLoS One. 2012;7(6):e38955. doi: 10.1371/journal.pone.0038955. Epub 2012 Jun 12.

9.

MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.

David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG.

Cancer Biol Ther. 2004 Jun;3(6):540-8. Epub 2004 Jun 10.

PMID:
15034303
10.
11.

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.

J Natl Cancer Inst. 2006 Mar 15;98(6):396-406.

PMID:
16537832
12.

Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.

Deng G, Kakar S, Okudiara K, Choi E, Sleisenger MH, Kim YS.

Clin Cancer Res. 2009 Mar 1;15(5):1519-26. doi: 10.1158/1078-0432.CCR-08-1778. Epub 2009 Feb 17.

13.

Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.

Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ.

Clin Cancer Res. 2009 Jun 1;15(11):3672-9. doi: 10.1158/1078-0432.CCR-08-2343. Epub 2009 May 19.

14.

Promoter CpG methylation in cancer cells contributes to the regulation of MUC4.

Yamada N, Nishida Y, Tsutsumida H, Goto M, Higashi M, Nomoto M, Yonezawa S.

Br J Cancer. 2009 Jan 27;100(2):344-51. doi: 10.1038/sj.bjc.6604845. Epub 2009 Jan 6.

15.
16.

Heparanase expression is associated with histone modifications in glioblastoma.

Hong X, Nelson K, Lemke N, Kalkanis SN.

Int J Oncol. 2012 Feb;40(2):494-500. doi: 10.3892/ijo.2011.1229. Epub 2011 Oct 13.

PMID:
22001963
17.

Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.

Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.

Mol Endocrinol. 2005 Jul;19(7):1740-51. Epub 2005 Mar 3.

PMID:
15746193
18.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

19.

Epigenetic regulation of gelsolin expression in human breast cancer cells.

Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB.

Exp Cell Res. 1999 May 25;249(1):161-76.

PMID:
10328963

Supplemental Content

Support Center